AMY JOY: Open Payments
NPI 1801962105 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 28 payments from 11 companies in 2025. Trend: 2023 $705 · 2024 $397 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $228 |
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| Neurocrine BioSciences, Inc. | 1 | $69 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| ABBVIE INC. | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Ozempic, BREZTRI, CRENESSITY, CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, SHINGRIX, FARXIGA.
Industry payments across IN — which companies pay providers there.
